K202885

Substantially Equivalent

GlucoSure HT Plus Blood Glucose Monitoring System

Applicant: Apex BioTechnology Corp.
Product code: NBW
Advisory panel: Clinical Chemistry
Date received: 2020-09-28
Decision date: 2021-09-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Hsinchu, CN

Adverse events under product code NBW

product code NBW

Death: 18
Injury: 4,740
Malfunction: 42,679
Other: 6
Total: 47,443

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.